Esther Rajavelu
Stock Analyst at UBS
(1.53)
# 3,208
Out of 4,670 analysts
26
Total ratings
60%
Success rate
-3.43%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Esther Rajavelu
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DNLI Denali Therapeutics | Maintains: Buy | $70 → $32 | $24.69 | +29.61% | 2 | Apr 9, 2024 | |
| APLT Applied Therapeutics | Maintains: Buy | $12 → $13 | $9.63 | +35.06% | 2 | Mar 15, 2024 | |
| ALNY Alnylam Pharmaceuticals | Upgrades: Buy | $141 → $215 | $244.89 | -12.21% | 5 | Oct 4, 2021 | |
| RARE Ultragenyx Pharmaceutical | Initiates: Sell | $73 | $47.24 | +54.53% | 1 | Aug 19, 2021 | |
| BHVN Biohaven | Downgrades: Neutral | $108 → $109 | $45.59 | +139.09% | 6 | Aug 10, 2021 | |
| STOK Stoke Therapeutics | Initiates: Neutral | $35 | $11.43 | +206.21% | 1 | May 18, 2021 | |
| IONS Ionis Pharmaceuticals | Upgrades: Neutral | $33 → $38 | $34.01 | +10.26% | 3 | May 7, 2021 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $174 → $228 | $126.67 | +80.00% | 1 | Mar 1, 2021 | |
| EYEN Eyenovia | Downgrades: Perform | n/a | $0.11 | - | 2 | Feb 3, 2020 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Perform | n/a | $18.54 | - | 1 | Dec 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $13 | $19.15 | -32.11% | 1 | Nov 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.37 | +629.93% | 1 | Jul 21, 2017 |
Denali Therapeutics
Apr 9, 2024
Maintains: Buy
Price Target: $70 → $32
Current: $24.69
Upside: +29.61%
Applied Therapeutics
Mar 15, 2024
Maintains: Buy
Price Target: $12 → $13
Current: $9.63
Upside: +35.06%
Alnylam Pharmaceuticals
Oct 4, 2021
Upgrades: Buy
Price Target: $141 → $215
Current: $244.89
Upside: -12.21%
Ultragenyx Pharmaceutical
Aug 19, 2021
Initiates: Sell
Price Target: $73
Current: $47.24
Upside: +54.53%
Biohaven
Aug 10, 2021
Downgrades: Neutral
Price Target: $108 → $109
Current: $45.59
Upside: +139.09%
Stoke Therapeutics
May 18, 2021
Initiates: Neutral
Price Target: $35
Current: $11.43
Upside: +206.21%
Ionis Pharmaceuticals
May 7, 2021
Upgrades: Neutral
Price Target: $33 → $38
Current: $34.01
Upside: +10.26%
Jazz Pharmaceuticals
Mar 1, 2021
Maintains: Buy
Price Target: $174 → $228
Current: $126.67
Upside: +80.00%
Eyenovia
Feb 3, 2020
Downgrades: Perform
Price Target: n/a
Current: $0.11
Upside: -
Arrowhead Pharmaceuticals
Dec 13, 2019
Initiates: Perform
Price Target: n/a
Current: $18.54
Upside: -
Nov 20, 2017
Initiates: Hold
Price Target: $13
Current: $19.15
Upside: -32.11%
Jul 21, 2017
Initiates: Buy
Price Target: $10
Current: $1.37
Upside: +629.93%